Cefixime

Product NDC: 16714-767
11-digit product format: 167140767
Labeler code: 16714
Product ID: 16714-767_f15f86c9-5ebe-800a-e053-2995a90af842
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: cefixime
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: NorthStar RxLLC
Application: ANDA206938
Marketing category: ANDA
Marketing start: 2018-05-11
Marketing end: 0000-00-00
Substance: CEFIXIME
Active strength: 200 mg/5mL
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2024-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	16714-767		D	Discontinued by firm	2026-08-17
excluded package	package	16714-767	16714-767-01	D	Discontinued by firm	2026-08-17
excluded package	package	16714-767	16714-767-02	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 27 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	16714-767-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	16714-767-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	16714-767-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	16714-767-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	16714-767-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	16714-767-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	16714-767-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	16714-767-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	16714-767-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	16714-767-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	16714-767-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	16714-767-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	16714-767-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	16714-767-02	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	16714-767-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	16714-767-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	16714-767-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	16714-767-02	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A206938-001	CEFIXIME	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB		2017-02-06
A206938-002	CEFIXIME	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB		2017-02-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A206938-001	AB
A206938-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A206938-001	CEFIXIME	100MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A206938-002	CEFIXIME	200MG/5ML	FOR SUSPENSION / ORAL	AB	2017-02-06	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A206938-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206938-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206938-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206938-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206938-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206938-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206938-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206938-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206938-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206938-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206938-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206938-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206938-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206938-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206938-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206938-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206938-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206938-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206938-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206938-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206938-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206938-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206938-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206938-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206938-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206938-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206938-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206938-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A206938-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A206938-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206938-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A206938-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A206938-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A206938-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A206938-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A206938-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A206938-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A206938-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A206938-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A206938-002	AB	1	`bb7c543d1eb4…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
16714-767-01	ML - Milliliter	16714-767	fd193cb8-5587-47f5-991a-53fa28cafb95	1	2018-06-11
16714-767-02	ML - Milliliter	16714-767	2e265db4-a38e-47de-a139-4c9aa37735e5	1	2018-06-11

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
97I1C92E55	CEFIXIME	125110-14-7	CEFIXIME

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
16714-767-01	16714076701	50 mL in 1 BOTTLE (16714-767-01)	50 ml	2018-05-11	0000-00-00	No	No	Current
16714-767-02	16714076702	75 mL in 1 BOTTLE (16714-767-02)	75 ml	2018-05-11	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cefixime	NorthStar RxLLC \| Belcher Pharmaceuticals,LLC	2023-01-03	HUMAN PRESCRIPTION DRUG LABEL	9